Verona Pharma plc (VRP.L) (LON:VRP – Get Free Report) crossed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of GBX 55 ($0.72) and traded as high as GBX 56 ($0.73). Verona Pharma plc (VRP.L) shares last traded at GBX 55 ($0.72), with a volume of 70,791 shares trading hands.
Verona Pharma plc (VRP.L) Stock Up 5.8 %
The company has a quick ratio of 2.47, a current ratio of 2.99 and a debt-to-equity ratio of 6.85. The stock has a 50-day simple moving average of GBX 55 and a two-hundred day simple moving average of GBX 55. The firm has a market cap of £228.00 million and a PE ratio of -1.68.
Verona Pharma plc (VRP.L) Company Profile
Verona Pharma plc, a clinical stage biopharmaceutical company, develops and commercializes therapeutics to treat respiratory diseases. The company's product candidate is RPL554, an inhaled dual inhibitor of the enzymes phosphodiesterase 3 and 4, which has completed Phase I and II clinical trials that acts as a bronchodilator and an anti-inflammatory agent for the treatment of chronic obstructive pulmonary disease, cystic fibrosis, chronic asthma, and allergic rhinitis.
Featured Articles
- Five stocks we like better than Verona Pharma plc (VRP.L)
- What Does a Stock Split Mean?
- Matador Resources Insiders Keep Buying Its Stock, Should You?
- How to Calculate Retirement Income: MarketBeat’s Calculator
- Oracle Can Turn the Magnificent 7 Into 8: Here’s Why
- Consumer Staples Stocks, Explained
- Palantir Stock Is Up 14% on S&P 500 News: Is It Time to Buy?
Receive News & Ratings for Verona Pharma plc (VRP.L) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Verona Pharma plc (VRP.L) and related companies with MarketBeat.com's FREE daily email newsletter.